Table 1. Correlation between HOXA-AS2 expression and clinicopathological characteristics of CRC patients.
Characteristics | Number (n=69) | Percent |
HOXA-AS2 |
Chi-squared test P-value | |
---|---|---|---|---|---|
High | Low | ||||
Age (years) | 0.053 | ||||
<60 | 38 | 55.1 | 15 | 23 | |
⩾60 | 31 | 44.9 | 20 | 11 | |
Gender | 0.797 | ||||
Male | 47 | 68.1 | 23 | 24 | |
Female | 22 | 31.9 | 12 | 10 | |
Maximum tumor size | 0.002a | ||||
<5 cm | 37 | 53.6 | 12 | 25 | |
⩾5 cm | 32 | 46.4 | 23 | 9 | |
Location | 0.332 | ||||
Colon | 40 | 58.0 | 18 | 22 | |
Rectum | 29 | 42.0 | 17 | 12 | |
Depth of tumor | 0.808 | ||||
T1 and T2 | 34 | 49.3 | 16 | 17 | |
T3 and T4 | 35 | 50.7 | 19 | 16 | |
Tumor stage | 0.004a | ||||
I and II | 21 | 30.4 | 5 | 16 | |
III and IV | 48 | 69.6 | 30 | 18 | |
Lymph node metastasis | 0.004a | ||||
Negative | 21 | 30.4 | 5 | 16 | |
Positive | 48 | 69.6 | 30 | 18 |
P<0.05 was considered significant (Chi-square test between two groups).